Seasonality Snapshot

AstraZeneca (AZN.L)

Pharmaceuticals · UK · UK Pharma & Health
✓ VERIFIED · 15YR REAL DATA
JanFebMarAprMayJunJulAugSepOctNovDec
NEUTRAL SEASONALITY — August
Strongest Month
April
+3.01% avg · 63% win rate
Weakest Month
August
-0.49% avg · 31% win rate
MonthAvg ReturnWin Rate
January +0.27% 44%
February +0.45% 44%
March +1.72% 56%
April +3.01% 63%
May +1.41% 56%
June +0.72% 50%
July +2.25% 69%
August NOW -0.49% 31%
September -0.12% 60%
October -0.10% 60%
November +1.05% 53%
December +0.81% 60%
These figures are computed from 15 years of actual monthly closing prices. Past seasonal patterns are not a guarantee of future performance. See our methodology for how this is calculated, or visit the Academy to learn how to read seasonal data responsibly.

AstraZeneca seasonality — common questions

What is AstraZeneca's best month historically?
Historically, April has been AstraZeneca's strongest month, averaging +3.01% with a 63% win rate over 15 years of data. August has been the weakest at -0.49%.
Is AstraZeneca seasonal?
AstraZeneca shows a measurable seasonal pattern: its best and worst months differ by 3.50 percentage points on average. These figures come from 15 years of real monthly closing prices. Seasonality is a historical tendency, not a prediction.
How does AstraZeneca historically perform in August?
AstraZeneca is currently in August, which has historically averaged -0.49% with a 31% win rate. That is a historically neutral window.

Get the full analysis

Backtest this seasonal pattern, compare it against other assets, set alerts, and explore detrended & presidential-cycle views.

Open the Analyzer →
TimingAX is an independently operated service, not a registered investment adviser. This page is for informational purposes only and is not financial advice.